Global LFA-based Cardiac Market Growth (Status and Outlook) 2025-2031

August 2025 | 102 pages | ID: GBA6A0BDDA27EN
LP Information

Abstracts

The global LFA-based Cardiac market size is predicted to grow from US$ 4381 million in 2025 to US$ 6148 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.

Lateral flow cardiac markers are a rapid detection tool based on lateral flow immunochromatography technology, which is used to qualitatively or quantitatively detect specific cardiac biomarkers in the blood (such as troponin I/T, myoglobin, BNP, etc.). The principle is to form a visual detection line on the test strip through antigen-antibody reaction, so as to quickly judge abnormal cardiac function or myocardial damage. This technology has the advantages of convenience, rapidity (results in 15-30 minutes), low cost, and no need for complex equipment. It is widely used in emergency, primary care, home self-testing and other scenarios.

Market drivers:

Disease demand growth:

Cardiovascular disease is the world's leading cause of death, with a large and growing patient base. China has more than 330 million cardiovascular disease patients, and there is an urgent need for early screening and immediate diagnosis.

Acute myocardial infarction, heart failure and other acute diseases require rapid testing (such as the demand for troponin immediate testing in chest pain centers), and lateral flow technology can shorten the diagnosis time and improve prognosis.

Policy promotion:

Tiered diagnosis and treatment: Policies guide the sinking of high-quality medical resources, and primary medical institutions (such as community hospitals and township health centers) need to be equipped with POCT (point-of-care testing) equipment. Lateral flow cardiac markers are the first choice because of their simple operation and low cost.

Medical insurance coverage: Some cardiac marker tests are included in medical insurance, reducing the burden on patients and improving the accessibility of testing.

Technology iteration:

Sensitivity improvement: The application of nanomaterials (such as gold nanoparticles) improves detection sensitivity and can detect low-concentration markers (such as high-sensitivity troponin).

Multi-indicator joint detection: The same test strip realizes the joint detection of multiple markers (such as troponin + BNP + D-dimer), improving diagnostic efficiency.

Intelligence: Combined with mobile phone APP or portable reader, the results can be automatically transmitted and interpreted to reduce human errors.

Application scenario expansion:

Pre-hospital emergency: rapid screening at ambulance and emergency scene, auxiliary decision-making (such as whether to transfer directly to the catheterization room).

Home monitoring: patients with chronic heart failure can self-test BNP at home and adjust drug dosage in time.

Physical examination screening: early cardiac function assessment for high-risk groups (such as patients with hypertension and diabetes).

Market trend:

Domestic substitution: domestic companies (such as Wondfo Biotech and Mindray Biotech) have made technological breakthroughs, breaking the import monopoly and reducing costs.

Standardized development: industry standards are gradually improved, promoting the transformation of product homogeneity to differentiated competition (such as specific marker detection and personalized services).

The lateral flow cardiac marker market is driven by disease demand, policy promotion, and technological upgrading. In the future, it will continue to develop in the direction of rapidity, multi-indicators, and intelligence, and become an important tool for the diagnosis and treatment of cardiovascular diseases.

LPI (LP Information)' newest research report, the “LFA-based Cardiac Industry Forecast” looks at past sales and reviews total world LFA-based Cardiac sales in 2024, providing a comprehensive analysis by region and market sector of projected LFA-based Cardiac sales for 2025 through 2031. With LFA-based Cardiac sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world LFA-based Cardiac industry.

This Insight Report provides a comprehensive analysis of the global LFA-based Cardiac landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on LFA-based Cardiac portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global LFA-based Cardiac market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for LFA-based Cardiac and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global LFA-based Cardiac.

This report presents a comprehensive overview, market shares, and growth opportunities of LFA-based Cardiac market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Troponin I
• Troponin T
• CK-MB
• Myoglobin
• Others

Segmentation by Application:

• Laboratory Testing
• Point-of-care Testing

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Roche
• Abbott
• Siemens
• Danaher
• Bio-Rad Laboratories
• BioMerieux
• Thermo Fisher
• Ortho Clinical Diagnostics
• LSI Medience Corporation
• Randox laboratories
• Wondfo Biotech
• EasyDiagnosis Biomedicine

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global LFA-based Cardiac Market Size (2020-2031)
  2.1.2 LFA-based Cardiac Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for LFA-based Cardiac by Country/Region (2020, 2024 & 2031)
2.2 LFA-based Cardiac Segment by Type
  2.2.1 Troponin I
  2.2.2 Troponin T
  2.2.3 CK-MB
  2.2.4 Myoglobin
  2.2.5 Others
2.3 LFA-based Cardiac Market Size by Type
  2.3.1 LFA-based Cardiac Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global LFA-based Cardiac Market Size Market Share by Type (2020-2025)
2.4 LFA-based Cardiac Segment by Application
  2.4.1 Laboratory Testing
  2.4.2 Point-of-care Testing
2.5 LFA-based Cardiac Market Size by Application
  2.5.1 LFA-based Cardiac Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global LFA-based Cardiac Market Size Market Share by Application (2020-2025)

3 LFA-BASED CARDIAC MARKET SIZE BY PLAYER

3.1 LFA-based Cardiac Market Size Market Share by Player
  3.1.1 Global LFA-based Cardiac Revenue by Player (2020-2025)
  3.1.2 Global LFA-based Cardiac Revenue Market Share by Player (2020-2025)
3.2 Global LFA-based Cardiac Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 LFA-BASED CARDIAC BY REGION

4.1 LFA-based Cardiac Market Size by Region (2020-2025)
4.2 Global LFA-based Cardiac Annual Revenue by Country/Region (2020-2025)
4.3 Americas LFA-based Cardiac Market Size Growth (2020-2025)
4.4 APAC LFA-based Cardiac Market Size Growth (2020-2025)
4.5 Europe LFA-based Cardiac Market Size Growth (2020-2025)
4.6 Middle East & Africa LFA-based Cardiac Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas LFA-based Cardiac Market Size by Country (2020-2025)
5.2 Americas LFA-based Cardiac Market Size by Type (2020-2025)
5.3 Americas LFA-based Cardiac Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC LFA-based Cardiac Market Size by Region (2020-2025)
6.2 APAC LFA-based Cardiac Market Size by Type (2020-2025)
6.3 APAC LFA-based Cardiac Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe LFA-based Cardiac Market Size by Country (2020-2025)
7.2 Europe LFA-based Cardiac Market Size by Type (2020-2025)
7.3 Europe LFA-based Cardiac Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa LFA-based Cardiac by Region (2020-2025)
8.2 Middle East & Africa LFA-based Cardiac Market Size by Type (2020-2025)
8.3 Middle East & Africa LFA-based Cardiac Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL LFA-BASED CARDIAC MARKET FORECAST

10.1 Global LFA-based Cardiac Forecast by Region (2026-2031)
  10.1.1 Global LFA-based Cardiac Forecast by Region (2026-2031)
  10.1.2 Americas LFA-based Cardiac Forecast
  10.1.3 APAC LFA-based Cardiac Forecast
  10.1.4 Europe LFA-based Cardiac Forecast
  10.1.5 Middle East & Africa LFA-based Cardiac Forecast
10.2 Americas LFA-based Cardiac Forecast by Country (2026-2031)
  10.2.1 United States Market LFA-based Cardiac Forecast
  10.2.2 Canada Market LFA-based Cardiac Forecast
  10.2.3 Mexico Market LFA-based Cardiac Forecast
  10.2.4 Brazil Market LFA-based Cardiac Forecast
10.3 APAC LFA-based Cardiac Forecast by Region (2026-2031)
  10.3.1 China LFA-based Cardiac Market Forecast
  10.3.2 Japan Market LFA-based Cardiac Forecast
  10.3.3 Korea Market LFA-based Cardiac Forecast
  10.3.4 Southeast Asia Market LFA-based Cardiac Forecast
  10.3.5 India Market LFA-based Cardiac Forecast
  10.3.6 Australia Market LFA-based Cardiac Forecast
10.4 Europe LFA-based Cardiac Forecast by Country (2026-2031)
  10.4.1 Germany Market LFA-based Cardiac Forecast
  10.4.2 France Market LFA-based Cardiac Forecast
  10.4.3 UK Market LFA-based Cardiac Forecast
  10.4.4 Italy Market LFA-based Cardiac Forecast
  10.4.5 Russia Market LFA-based Cardiac Forecast
10.5 Middle East & Africa LFA-based Cardiac Forecast by Region (2026-2031)
  10.5.1 Egypt Market LFA-based Cardiac Forecast
  10.5.2 South Africa Market LFA-based Cardiac Forecast
  10.5.3 Israel Market LFA-based Cardiac Forecast
  10.5.4 Turkey Market LFA-based Cardiac Forecast
10.6 Global LFA-based Cardiac Forecast by Type (2026-2031)
10.7 Global LFA-based Cardiac Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market LFA-based Cardiac Forecast

11 KEY PLAYERS ANALYSIS

11.1 Roche
  11.1.1 Roche Company Information
  11.1.2 Roche LFA-based Cardiac Product Offered
  11.1.3 Roche LFA-based Cardiac Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Roche Main Business Overview
  11.1.5 Roche Latest Developments
11.2 Abbott
  11.2.1 Abbott Company Information
  11.2.2 Abbott LFA-based Cardiac Product Offered
  11.2.3 Abbott LFA-based Cardiac Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Abbott Main Business Overview
  11.2.5 Abbott Latest Developments
11.3 Siemens
  11.3.1 Siemens Company Information
  11.3.2 Siemens LFA-based Cardiac Product Offered
  11.3.3 Siemens LFA-based Cardiac Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Siemens Main Business Overview
  11.3.5 Siemens Latest Developments
11.4 Danaher
  11.4.1 Danaher Company Information
  11.4.2 Danaher LFA-based Cardiac Product Offered
  11.4.3 Danaher LFA-based Cardiac Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Danaher Main Business Overview
  11.4.5 Danaher Latest Developments
11.5 Bio-Rad Laboratories
  11.5.1 Bio-Rad Laboratories Company Information
  11.5.2 Bio-Rad Laboratories LFA-based Cardiac Product Offered
  11.5.3 Bio-Rad Laboratories LFA-based Cardiac Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Bio-Rad Laboratories Main Business Overview
  11.5.5 Bio-Rad Laboratories Latest Developments
11.6 BioM?rieux
  11.6.1 BioM?rieux Company Information
  11.6.2 BioM?rieux LFA-based Cardiac Product Offered
  11.6.3 BioM?rieux LFA-based Cardiac Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 BioM?rieux Main Business Overview
  11.6.5 BioM?rieux Latest Developments
11.7 Thermo Fisher
  11.7.1 Thermo Fisher Company Information
  11.7.2 Thermo Fisher LFA-based Cardiac Product Offered
  11.7.3 Thermo Fisher LFA-based Cardiac Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Thermo Fisher Main Business Overview
  11.7.5 Thermo Fisher Latest Developments
11.8 Ortho Clinical Diagnostics
  11.8.1 Ortho Clinical Diagnostics Company Information
  11.8.2 Ortho Clinical Diagnostics LFA-based Cardiac Product Offered
  11.8.3 Ortho Clinical Diagnostics LFA-based Cardiac Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Ortho Clinical Diagnostics Main Business Overview
  11.8.5 Ortho Clinical Diagnostics Latest Developments
11.9 LSI Medience Corporation
  11.9.1 LSI Medience Corporation Company Information
  11.9.2 LSI Medience Corporation LFA-based Cardiac Product Offered
  11.9.3 LSI Medience Corporation LFA-based Cardiac Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 LSI Medience Corporation Main Business Overview
  11.9.5 LSI Medience Corporation Latest Developments
11.10 Randox laboratories
  11.10.1 Randox laboratories Company Information
  11.10.2 Randox laboratories LFA-based Cardiac Product Offered
  11.10.3 Randox laboratories LFA-based Cardiac Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Randox laboratories Main Business Overview
  11.10.5 Randox laboratories Latest Developments
11.11 Wondfo Biotech
  11.11.1 Wondfo Biotech Company Information
  11.11.2 Wondfo Biotech LFA-based Cardiac Product Offered
  11.11.3 Wondfo Biotech LFA-based Cardiac Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Wondfo Biotech Main Business Overview
  11.11.5 Wondfo Biotech Latest Developments
11.12 EasyDiagnosis Biomedicine
  11.12.1 EasyDiagnosis Biomedicine Company Information
  11.12.2 EasyDiagnosis Biomedicine LFA-based Cardiac Product Offered
  11.12.3 EasyDiagnosis Biomedicine LFA-based Cardiac Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 EasyDiagnosis Biomedicine Main Business Overview
  11.12.5 EasyDiagnosis Biomedicine Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. LFA-based Cardiac Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. LFA-based Cardiac Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Troponin I
Table 4. Major Players of Troponin T
Table 5. Major Players of CK-MB
Table 6. Major Players of Myoglobin
Table 7. Major Players of Others
Table 8. LFA-based Cardiac Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global LFA-based Cardiac Market Size by Type (2020-2025) & ($ millions)
Table 10. Global LFA-based Cardiac Market Size Market Share by Type (2020-2025)
Table 11. LFA-based Cardiac Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global LFA-based Cardiac Market Size by Application (2020-2025) & ($ millions)
Table 13. Global LFA-based Cardiac Market Size Market Share by Application (2020-2025)
Table 14. Global LFA-based Cardiac Revenue by Player (2020-2025) & ($ millions)
Table 15. Global LFA-based Cardiac Revenue Market Share by Player (2020-2025)
Table 16. LFA-based Cardiac Key Players Head office and Products Offered
Table 17. LFA-based Cardiac Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global LFA-based Cardiac Market Size by Region (2020-2025) & ($ millions)
Table 21. Global LFA-based Cardiac Market Size Market Share by Region (2020-2025)
Table 22. Global LFA-based Cardiac Revenue by Country/Region (2020-2025) & ($ millions)
Table 23. Global LFA-based Cardiac Revenue Market Share by Country/Region (2020-2025)
Table 24. Americas LFA-based Cardiac Market Size by Country (2020-2025) & ($ millions)
Table 25. Americas LFA-based Cardiac Market Size Market Share by Country (2020-2025)
Table 26. Americas LFA-based Cardiac Market Size by Type (2020-2025) & ($ millions)
Table 27. Americas LFA-based Cardiac Market Size Market Share by Type (2020-2025)
Table 28. Americas LFA-based Cardiac Market Size by Application (2020-2025) & ($ millions)
Table 29. Americas LFA-based Cardiac Market Size Market Share by Application (2020-2025)
Table 30. APAC LFA-based Cardiac Market Size by Region (2020-2025) & ($ millions)
Table 31. APAC LFA-based Cardiac Market Size Market Share by Region (2020-2025)
Table 32. APAC LFA-based Cardiac Market Size by Type (2020-2025) & ($ millions)
Table 33. APAC LFA-based Cardiac Market Size by Application (2020-2025) & ($ millions)
Table 34. Europe LFA-based Cardiac Market Size by Country (2020-2025) & ($ millions)
Table 35. Europe LFA-based Cardiac Market Size Market Share by Country (2020-2025)
Table 36. Europe LFA-based Cardiac Market Size by Type (2020-2025) & ($ millions)
Table 37. Europe LFA-based Cardiac Market Size by Application (2020-2025) & ($ millions)
Table 38. Middle East & Africa LFA-based Cardiac Market Size by Region (2020-2025) & ($ millions)
Table 39. Middle East & Africa LFA-based Cardiac Market Size by Type (2020-2025) & ($ millions)
Table 40. Middle East & Africa LFA-based Cardiac Market Size by Application (2020-2025) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of LFA-based Cardiac
Table 42. Key Market Challenges & Risks of LFA-based Cardiac
Table 43. Key Industry Trends of LFA-based Cardiac
Table 44. Global LFA-based Cardiac Market Size Forecast by Region (2026-2031) & ($ millions)
Table 45. Global LFA-based Cardiac Market Size Market Share Forecast by Region (2026-2031)
Table 46. Global LFA-based Cardiac Market Size Forecast by Type (2026-2031) & ($ millions)
Table 47. Global LFA-based Cardiac Market Size Forecast by Application (2026-2031) & ($ millions)
Table 48. Roche Details, Company Type, LFA-based Cardiac Area Served and Its Competitors
Table 49. Roche LFA-based Cardiac Product Offered
Table 50. Roche LFA-based Cardiac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 51. Roche Main Business
Table 52. Roche Latest Developments
Table 53. Abbott Details, Company Type, LFA-based Cardiac Area Served and Its Competitors
Table 54. Abbott LFA-based Cardiac Product Offered
Table 55. Abbott LFA-based Cardiac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 56. Abbott Main Business
Table 57. Abbott Latest Developments
Table 58. Siemens Details, Company Type, LFA-based Cardiac Area Served and Its Competitors
Table 59. Siemens LFA-based Cardiac Product Offered
Table 60. Siemens LFA-based Cardiac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 61. Siemens Main Business
Table 62. Siemens Latest Developments
Table 63. Danaher Details, Company Type, LFA-based Cardiac Area Served and Its Competitors
Table 64. Danaher LFA-based Cardiac Product Offered
Table 65. Danaher LFA-based Cardiac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 66. Danaher Main Business
Table 67. Danaher Latest Developments
Table 68. Bio-Rad Laboratories Details, Company Type, LFA-based Cardiac Area Served and Its Competitors
Table 69. Bio-Rad Laboratories LFA-based Cardiac Product Offered
Table 70. Bio-Rad Laboratories LFA-based Cardiac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 71. Bio-Rad Laboratories Main Business
Table 72. Bio-Rad Laboratories Latest Developments
Table 73. BioMerieux Details, Company Type, LFA-based Cardiac Area Served and Its Competitors
Table 74. BioMerieux LFA-based Cardiac Product Offered
Table 75. BioMerieux LFA-based Cardiac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 76. BioMerieux Main Business
Table 77. BioMerieux Latest Developments
Table 78. Thermo Fisher Details, Company Type, LFA-based Cardiac Area Served and Its Competitors
Table 79. Thermo Fisher LFA-based Cardiac Product Offered
Table 80. Thermo Fisher LFA-based Cardiac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 81. Thermo Fisher Main Business
Table 82. Thermo Fisher Latest Developments
Table 83. Ortho Clinical Diagnostics Details, Company Type, LFA-based Cardiac Area Served and Its Competitors
Table 84. Ortho Clinical Diagnostics LFA-based Cardiac Product Offered
Table 85. Ortho Clinical Diagnostics LFA-based Cardiac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 86. Ortho Clinical Diagnostics Main Business
Table 87. Ortho Clinical Diagnostics Latest Developments
Table 88. LSI Medience Corporation Details, Company Type, LFA-based Cardiac Area Served and Its Competitors
Table 89. LSI Medience Corporation LFA-based Cardiac Product Offered
Table 90. LSI Medience Corporation LFA-based Cardiac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 91. LSI Medience Corporation Main Business
Table 92. LSI Medience Corporation Latest Developments
Table 93. Randox laboratories Details, Company Type, LFA-based Cardiac Area Served and Its Competitors
Table 94. Randox laboratories LFA-based Cardiac Product Offered
Table 95. Randox laboratories LFA-based Cardiac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 96. Randox laboratories Main Business
Table 97. Randox laboratories Latest Developments
Table 98. Wondfo Biotech Details, Company Type, LFA-based Cardiac Area Served and Its Competitors
Table 99. Wondfo Biotech LFA-based Cardiac Product Offered
Table 100. Wondfo Biotech LFA-based Cardiac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 101. Wondfo Biotech Main Business
Table 102. Wondfo Biotech Latest Developments
Table 103. EasyDiagnosis Biomedicine Details, Company Type, LFA-based Cardiac Area Served and Its Competitors
Table 104. EasyDiagnosis Biomedicine LFA-based Cardiac Product Offered
Table 105. EasyDiagnosis Biomedicine LFA-based Cardiac Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 106. EasyDiagnosis Biomedicine Main Business
Table 107. EasyDiagnosis Biomedicine Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. LFA-based Cardiac Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global LFA-based Cardiac Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. LFA-based Cardiac Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. LFA-based Cardiac Sales Market Share by Country/Region (2024)
Figure 8. LFA-based Cardiac Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global LFA-based Cardiac Market Size Market Share by Type in 2024
Figure 10. LFA-based Cardiac in Laboratory Testing
Figure 11. Global LFA-based Cardiac Market: Laboratory Testing (2020-2025) & ($ millions)
Figure 12. LFA-based Cardiac in Point-of-care Testing
Figure 13. Global LFA-based Cardiac Market: Point-of-care Testing (2020-2025) & ($ millions)
Figure 14. Global LFA-based Cardiac Market Size Market Share by Application in 2024
Figure 15. Global LFA-based Cardiac Revenue Market Share by Player in 2024
Figure 16. Global LFA-based Cardiac Market Size Market Share by Region (2020-2025)
Figure 17. Americas LFA-based Cardiac Market Size 2020-2025 ($ millions)
Figure 18. APAC LFA-based Cardiac Market Size 2020-2025 ($ millions)
Figure 19. Europe LFA-based Cardiac Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa LFA-based Cardiac Market Size 2020-2025 ($ millions)
Figure 21. Americas LFA-based Cardiac Value Market Share by Country in 2024
Figure 22. United States LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC LFA-based Cardiac Market Size Market Share by Region in 2024
Figure 27. APAC LFA-based Cardiac Market Size Market Share by Type (2020-2025)
Figure 28. APAC LFA-based Cardiac Market Size Market Share by Application (2020-2025)
Figure 29. China LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 33. India LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe LFA-based Cardiac Market Size Market Share by Country in 2024
Figure 36. Europe LFA-based Cardiac Market Size Market Share by Type (2020-2025)
Figure 37. Europe LFA-based Cardiac Market Size Market Share by Application (2020-2025)
Figure 38. Germany LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 39. France LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 40. UK LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa LFA-based Cardiac Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa LFA-based Cardiac Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa LFA-based Cardiac Market Size Market Share by Application (2020-2025)
Figure 46. Egypt LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries LFA-based Cardiac Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 52. APAC LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 53. Europe LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 55. United States LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 56. Canada LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 57. Mexico LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 58. Brazil LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 59. China LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 60. Japan LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 61. Korea LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 63. India LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 64. Australia LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 65. Germany LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 66. France LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 67. UK LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 68. Italy LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 69. Russia LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 70. Egypt LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 71. South Africa LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 72. Israel LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 73. Turkey LFA-based Cardiac Market Size 2026-2031 ($ millions)
Figure 74. Global LFA-based Cardiac Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global LFA-based Cardiac Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries LFA-based Cardiac Market Size 2026-2031 ($ millions)